Evidence map›Paper›PMID 41542421›Full record

ArticlebioRxiv : the preprint server for biology2026

Dual-mode ClfA-targeting DARPin biologics protect against diverse methicillin-resistant

Karuppiah Chockalingam, Biswarup Banerjee, Yu Zeng, Shuyu Miao, Joshua Bryant, Dominique Missiakas, Zhilei Chen

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karuppiah ChockalingamDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, USA.
Biswarup BanerjeeDepartment of Microbiology, Howard Taylor Ricketts Laboratory, The University of Chicago, Lemont, IL, USA.
Yu ZengDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, USA.
Shuyu MiaoDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, USA.
Joshua BryantDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, USA.
Dominique MissiakasDepartment of Microbiology, Howard Taylor Ricketts Laboratory, The University of Chicago, Lemont, IL, USA.
Zhilei ChenDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, USA.

Funding

DARPin-based therapeutics against S. aureus infectionR21AI182950 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Zhilei Chen · 2025 to 2026
$443k
NIAID NIH HHS R21 AI182950
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41542421
PMCPMC12803223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.